Skip to main content

Advertisement

Log in

Vocal cord paralysis during the treatment of mantle cell lymphoma with vincristine

  • Case Report
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Case description We present a case of a seventy-eight year-old man who developed vocal cord paralysis without any sign of peripheral neuropathy during the treatment of Mantle Cell Lymphoma. He first presented in 2008 with a few bilateral small inguinal lymph nodes. Inguinal lymph node biopsy demonstrated Mantle Cell Lymphoma. Flow cytometry studies of peripheral blood and bone marrow cells were compatible with Mantle Cell Lymphoma. R-CHOP chemotherapy triweekly (Rituximab; Cyclophosphamide; Adriamycin; Vincristine; and Methylprednisolone) was planned. At the end of the second cycle, the patient complained of hoarseness without any symptoms of dysphagia or odynophagia. Direct flexible laryngoscopy showed bilateral vocal cord paralysis. Vincristine was discontinued and the patient’s voice gradually resolved in about 4 months. Conclusion Vincristine may cause peripheral, autonomic and cranial neuropathies. However cranial nerve involvement is quite uncommon.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sahenk Z, Brady ST, Mendell JR. Studies on the pathogenesis of vincristine-induced neuropathy. Muscle Nerve. 1987;10:80–4.

    Article  PubMed  CAS  Google Scholar 

  2. Green LS, Donoso JA, Heller-Bettinger IE, Samson FE. Axonal transport disturbances in vincristine-induced peripheral neuropathy. Ann Neurol. 1977;1(3):255–62.

    Article  PubMed  CAS  Google Scholar 

  3. Oakes SG, Santone KS, Powis G. Effect of some anticancer drugs on the surface membrane electrical properties of differentiated murine neuroblastoma cells. J Natl Cancer Inst. 1987;79:155–61.

    PubMed  CAS  Google Scholar 

  4. Chauvenet AR, Shashi V, Selsky C, Morgan E, Kurtzberg J, Bell B. Vincristine-induced neuropathy as the initial presentation of Charcot-Marie-Tooth disease in acute lymphoblastic leukemia: a pediatric oncology group study. J Pediatr Hematol Oncol. 2003;25(4):316–20.

    Article  PubMed  Google Scholar 

  5. Bradley WG, Lassman LP, Pearce GW, Walton JN. The neuromyopathy of vincristine in man: clinical, electrophysiological, and pathological studies. J Neurol Sci. 1970;10(2):107–31.

    Article  PubMed  CAS  Google Scholar 

  6. Sahenk Z, Brady ST, Mendell JR. Studies on the pathogenesis of vincristine induced neuropathy. Muscle Nerve. 1987;10(1):80–4.

    Article  PubMed  CAS  Google Scholar 

  7. Tuxen MK, Hansen SW. Neurotoxicity secondary to antineoplastic drugs. Cancer Treat Rev. 1994;20(2):191–214.

    Article  PubMed  CAS  Google Scholar 

  8. Bohannon RA, Miller DG, Diamond HD. Vincristine in the treatment of lymphomas and leukemia. Cancer Res. 1963;23:613–21.

    PubMed  CAS  Google Scholar 

  9. Bay A, Yilmaz C, Yilmaz N, Oner AF. Vincristine induced cranial polyneuropathy. Indian J Pediatr. 2006;73:531–3.

    Article  PubMed  Google Scholar 

  10. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.

    Article  PubMed  CAS  Google Scholar 

  11. Kuruvilla G, Perry S, Wilson B, El-Hakim H. The natural history of vincristine-induced laryngeal paralysis in children. Arch Otolaryngol Head Neck Surg. 2009;135(1):101–5.

    Article  PubMed  Google Scholar 

  12. Naithani R, Dolai TK, Kumar R. Bilateral vocal cord paralysis following treatment with vincristine. Indian Pediatr. 2009;46(1):68–9.

    PubMed  Google Scholar 

  13. Latiff ZA, Kamal NA, Jahendran J, Alias H, Goh BS, Syed Zakaria SZ, et al. Vincristine-induced vocal cord palsy: case report and review of the literature. J Pediatr Hematol Oncol. 2010;32(5):407–10.

    Article  PubMed  Google Scholar 

  14. Farruggia P, Tropia S, Cannella S, Bruno G, Oddo G, D’Angelo P. Vocal cord palsy after vincristine treatment in a child and the inefficacy of glutamic acid in the prevention of relapse: a case report. J Med Case Rep. 2012;6(1):128.

    Article  PubMed  Google Scholar 

  15. Whittaker JA, Griffith IP. Recurrent laryngeal nerve paralysis in patients receiving vincristine and vinblastine. Br Med J. 1977;1:1251–2.

    Article  PubMed  CAS  Google Scholar 

  16. Rezvani K, Bain BJ, Coulter CA. Loss of singing ability caused by vincristine. Clin Lab Haematol. 1998;20(1):47–8.

    Article  PubMed  CAS  Google Scholar 

  17. Anghelescu DL, De Armendi AJ, Thompson JW, Sillos EM, Pui CH, Sandlund JT. Vincristine induced vocal cord paralysis in an infant. Paediatr Anaesth. 2002;12:168–70.

    Article  PubMed  Google Scholar 

  18. Jeng MR, Feusner J. Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2001;18:137–42.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mehmet Riza Altiparmak.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yalin, S.F., Trabulus, S., Yalin, A.S. et al. Vocal cord paralysis during the treatment of mantle cell lymphoma with vincristine. Int J Clin Pharm 35, 306–308 (2013). https://doi.org/10.1007/s11096-013-9751-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-013-9751-6

Keywords

Navigation